Antineoplastic composition and use thereof
Patent Information
- Authority / Receiving Office
- CN Β· China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- NANJING MEDICAL UNIV
- Publication Date
- 2008-12-31
- Estimated Expiration
- Not applicable Β· inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the field of pharmacy, and relates to an antitumor composition and its application. Background technique
[0002] Since Rosenberg et al. [1] discovered that platinum group compounds have anticancer activity in 1965, the research and application of platinum group metal anticancer drugs have developed rapidly. Cisplatin (cisplatin, cis-dichlorodiammine platinum, Cisplatin, Cis-Diaminodichloroplatin Platinol, CDDP) is one of the most effective. CDDP has the characteristics of broad anti-cancer spectrum, strong effect, and synergistic effect with various anti-tumor drugs. It is one of the most commonly used drugs in current combination chemotherapy. Esophageal cancer, malignant lymphoma, breast cancer, head and neck squamous cell carcinoma, thyroid cancer and osteosarcoma and other solid tumors can show curative effect. [2]. According to statistics, in my country, CDDP-based or compatible chemotherapy regimens with CDDP account ...